{"transactions":[{"id":2526411,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":1,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":2,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":3,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":5,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T20:17:40.000Z","date":"2021-11-01","kind":"other","acquired":true,"shares":8276,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares received by the James B. Tananbaum and Dana Shonfeld Tananbaum Family Trust pursuant to pro rata distributions by Fund III and FCM III, for no consideration, of shares of the Issuer's Common Stock to their respective partners or members, as applicable. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held of record by a family trust for which Mr. Tananbaum is a trustee. Each of the Reporting Persons disclaims the existence of a \"group\" and, other than Mr. Tananbaum, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8276,"source":{"system":"sec-edgar","filing":"0001209191-21-062697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919121062697/doc4.xml","form_type":"4"}},{"id":2526410,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":1,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":2,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":3,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25098,"kind":"organization","name":"Foresite Capital Management V, LLC","position":5,"cik":"0001792206","reported_name":"Foresite Capital Management V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25099,"kind":"organization","name":"Foresite Capital Fund V, L.P.","position":6,"cik":"0001792204","reported_name":"Foresite Capital Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T20:17:40.000Z","date":"2021-11-01","kind":"other","acquired":false,"shares":1954904,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 1, 2021, Foresite Capital Fund III, L.P. (\"Fund III\") distributed, for no consideration, 1,954,904 shares of the Issuer's Common Stock (the \"Fund III Shares\") to its limited partners and to Foresite Capital Management III, LLC (\"FCM III\"), the general partner of Fund III, representing each such partner's pro rata interest in such Fund III Shares. On the same date, FCM III distributed, for no consideration, the Fund III Shares it received in the distribution by Fund III to its members, representing each such member's pro rata interest in such Fund III Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Fund III. FCM III is the general partner of Fund III, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\") is the sole managing member of FCM III and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-062697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919121062697/doc4.xml","form_type":"4"}},{"id":3238370,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":3,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":5,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":6,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T22:01:47.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":271767,"price":17.07,"value":4639062.69,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1229633,"source":{"system":"sec-edgar","filing":"0001209191-20-014562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919120014562/doc4.xml","form_type":"4"}},{"id":3238369,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":3,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":5,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":6,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T22:01:47.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":425457,"price":17.07,"value":7262550.99,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1925020,"source":{"system":"sec-edgar","filing":"0001209191-20-014562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919120014562/doc4.xml","form_type":"4"}},{"id":3238368,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":3,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":4,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":5,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":6,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T22:01:47.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":302776,"price":17.07,"value":5168386.32,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund II, L.P. (\"FCF II\"). Foresite Capital Management II, LLC (\"FCM II\"), the general partner of FCF II, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM II, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM II and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM II and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1369938,"source":{"system":"sec-edgar","filing":"0001209191-20-014562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919120014562/doc4.xml","form_type":"4"}},{"id":3420668,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-07T00:28:16.000Z","date":"2019-09-05","kind":"purchase","acquired":true,"shares":15700,"price":18.42,"value":289194.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $18.25 to $18.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2350477,"source":{"system":"sec-edgar","filing":"0001209191-19-048830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048830/doc4.xml","form_type":"4"}},{"id":3420667,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-07T00:28:16.000Z","date":"2019-09-04","kind":"purchase","acquired":true,"shares":90900,"price":18.48,"value":1679832.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $18.12 to $18.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general partner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1400900,"source":{"system":"sec-edgar","filing":"0001209191-19-048830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048830/doc4.xml","form_type":"4"}},{"id":3420666,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-07T00:28:16.000Z","date":"2019-09-04","kind":"purchase","acquired":true,"shares":9300,"price":18.48,"value":171864.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $18.12 to $18.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2334777,"source":{"system":"sec-edgar","filing":"0001209191-19-048830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048830/doc4.xml","form_type":"4"}},{"id":3423396,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T00:38:56.000Z","date":"2019-09-03","kind":"purchase","acquired":true,"shares":15100,"price":21.45,"value":323895.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $21.23 to $21.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2325477,"source":{"system":"sec-edgar","filing":"0001209191-19-048394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048394/doc4.xml","form_type":"4"}},{"id":3423395,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T00:38:56.000Z","date":"2019-09-03","kind":"purchase","acquired":true,"shares":34900,"price":20.54,"value":716846.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $20.23 to $21.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2310377,"source":{"system":"sec-edgar","filing":"0001209191-19-048394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048394/doc4.xml","form_type":"4"}},{"id":3423394,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T00:38:56.000Z","date":"2019-08-30","kind":"purchase","acquired":true,"shares":25000,"price":21.36,"value":534000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $21.00 to $21.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2275477,"source":{"system":"sec-edgar","filing":"0001209191-19-048394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119048394/doc4.xml","form_type":"4"}},{"id":3430270,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-24T00:52:41.000Z","date":"2019-08-23","kind":"purchase","acquired":true,"shares":38300,"price":23.42,"value":896986.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $23.295 to $23.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2250477,"source":{"system":"sec-edgar","filing":"0001209191-19-047387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119047387/doc4.xml","form_type":"4"}},{"id":3430269,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-24T00:52:41.000Z","date":"2019-08-22","kind":"purchase","acquired":true,"shares":6700,"price":23.68,"value":158656.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $23.48 to $23.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2212177,"source":{"system":"sec-edgar","filing":"0001209191-19-047387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119047387/doc4.xml","form_type":"4"}},{"id":3430268,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-24T00:52:41.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":1153,"price":23.25,"value":26807.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2205477,"source":{"system":"sec-edgar","filing":"0001209191-19-047387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119047387/doc4.xml","form_type":"4"}},{"id":3433285,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T00:27:57.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":50000,"price":23.21,"value":1160500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $22.82 to $23.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2204324,"source":{"system":"sec-edgar","filing":"0001209191-19-046913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046913/doc4.xml","form_type":"4"}},{"id":3433284,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T00:27:57.000Z","date":"2019-08-19","kind":"purchase","acquired":true,"shares":3847,"price":23.34,"value":89788.98,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $23.22 to $23.42. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2154324,"source":{"system":"sec-edgar","filing":"0001209191-19-046913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046913/doc4.xml","form_type":"4"}},{"id":3433283,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T00:27:57.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":100000,"price":24.23,"value":2423000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $23.73 to $24.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2150477,"source":{"system":"sec-edgar","filing":"0001209191-19-046913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046913/doc4.xml","form_type":"4"}},{"id":3438840,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T00:15:51.000Z","date":"2019-08-14","kind":"purchase","acquired":true,"shares":100000,"price":23.73,"value":2373000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $23.50 to $24.05. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":2050477,"source":{"system":"sec-edgar","filing":"0001209191-19-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046012/doc4.xml","form_type":"4"}},{"id":3438839,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T00:15:51.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":178903,"price":25.52,"value":4565604.56,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $25.16 to $25.70. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1310000,"source":{"system":"sec-edgar","filing":"0001209191-19-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046012/doc4.xml","form_type":"4"}},{"id":3438838,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T00:15:51.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":71097,"price":24.92,"value":1771737.24,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $24.15 to $25.15. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1131097,"source":{"system":"sec-edgar","filing":"0001209191-19-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046012/doc4.xml","form_type":"4"}},{"id":3438837,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67424,"kind":"organization","name":"Foresite Capital Management IV, LLC","position":5,"cik":"0001704132","reported_name":"Foresite Capital Management IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67425,"kind":"organization","name":"Foresite Capital Fund IV, L.P.","position":6,"cik":"0001704131","reported_name":"Foresite Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":7,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-08-15T00:15:51.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":189555,"price":24.43,"value":4630828.65,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $23.99 to $24.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund IV, L.P. (\"FCF IV\"). Foresite Capital Management IV, LLC (\"FCM IV\"), the general\npartner of FCF IV, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing\nmember of FCM IV, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the\nexistence of a \"group.\" Each of FCM IV and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM IV and its members or Mr. Tananbaum is\nthe beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1060000,"source":{"system":"sec-edgar","filing":"0001209191-19-046012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704131/000120919119046012/doc4.xml","form_type":"4"}},{"id":4299971,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":3,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":4,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T19:12:32.000Z","date":"2017-05-26","kind":"sale","acquired":false,"shares":10182,"price":55.95,"value":569682.9,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. Mr. Tananbaum, in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1950477,"source":{"system":"sec-edgar","filing":"0001209191-17-036603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645157/000120919117036603/doc4.xml","form_type":"4"}},{"id":4299970,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":3,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":4,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T19:12:32.000Z","date":"2017-05-26","kind":"sale","acquired":false,"shares":9818,"price":55.95,"value":549317.1,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund II, L.P. (\"FCF II\"). Foresite Capital Management II, LLC (\"FCM II\"), the general partner of FCF II, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM II, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM II and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM II and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1672714,"source":{"system":"sec-edgar","filing":"0001209191-17-036603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645157/000120919117036603/doc4.xml","form_type":"4"}},{"id":4581588,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-11T13:05:47.000Z","date":"2016-10-06","kind":"sale","acquired":false,"shares":25187,"price":40.3399,"value":1016041.0613,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $40.00 to $40.90.  The price reported reflects the weighted average sale price.  The Reporting Persons hereby undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares and the price at which each trade was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\"). Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a \"group.\" Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1672697,"source":{"system":"sec-edgar","filing":"0001209191-16-145532","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645157/000120919116145532/doc4a.xml","form_type":"4/A","original_submission_date":"2016-10-07"}},{"id":4581587,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-11T13:05:47.000Z","date":"2016-10-06","kind":"sale","acquired":false,"shares":24813,"price":40.3399,"value":1000953.9387,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $40.00 to $40.90.  The price reported reflects the weighted average sale price.  The Reporting Persons hereby undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares and the price at which each trade was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund II, L.P. (\"FCF II\"). Foresite Capital Management II, LLC (\"FCM II\"), the general partner of\nFCF II, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity\nas managing member of FCM II, may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims\nthe existence of a \"group.\" Each of FCM II and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to\nthe extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM II and its members or Mr. Tananbaum is the\nbeneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1647901,"source":{"system":"sec-edgar","filing":"0001209191-16-145532","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645157/000120919116145532/doc4a.xml","form_type":"4/A","original_submission_date":"2016-10-07"}},{"id":4582573,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-07T21:12:44.000Z","date":"2016-10-06","kind":"sale","acquired":false,"shares":25187,"price":40.3399,"value":1016041.0613,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Foresite Capital Fund III, L.P. (\"FCF III\").  Foresite Capital Management III, LLC (\"FCM III\"), the general partner of FCF III, may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM III, may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1672697,"source":{"system":"sec-edgar","filing":"0001209191-16-145487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645157/000120919116145487/doc4.xml","form_type":"4"}},{"id":4582572,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":119856,"kind":"organization","name":"Foresite Capital Management II, LLC","position":1,"cik":"0001594912","reported_name":"Foresite Capital Management II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":149232,"kind":"organization","name":"Foresite Capital Fund II, L.P.","position":2,"cik":"0001594914","reported_name":"Foresite Capital Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":119963,"kind":"organization","name":"Foresite Capital Management III, LLC","position":3,"cik":"0001645157","reported_name":"Foresite Capital Management III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":133886,"kind":"organization","name":"Foresite Capital Fund III, L.P.","position":4,"cik":"0001645158","reported_name":"Foresite Capital Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":25096,"kind":"person","name":"Tananbaum James B.","position":5,"cik":"0001581754","reported_name":"Tananbaum James B.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-07T21:12:44.000Z","date":"2016-10-06","kind":"sale","acquired":false,"shares":24813,"price":40.3399,"value":1000953.9387,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are owned directly by Foresite Capital Fund II, L.P. (\"FCF II\").  Foresite Capital Management II, LLC (\"FCM II\"), the general partner of FCF II, may be deemed to have sole voting and dispositive power over these shares.  James B. Tananbaum (\"Mr. Tananbaum\"), in his capacity as managing member of FCM II, may be deemed to have sole voting and dispositive power over these shares.  Each Reporting Person disclaims the existence of a \"group.\"  Each of FCM II and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM II and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose."}],"balance_after":1647901,"source":{"system":"sec-edgar","filing":"0001209191-16-145487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645157/000120919116145487/doc4.xml","form_type":"4"}}]}